 "A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai. Photo: Reuters")
In a setback to India's biggest pharma company, the Delhi High Court recently refused to provide Sun Pharmaceuticals any interim relief in their trademark infringement case against rival drug manufacturer Mylan Laboratories for the production of the cancer medication Oxaliplatin. Sun Pharmaceuticals and Mylan are also at loggerheads at the Intellectual Property Appellate Tribunal (IPAB) on the same issue and are both seeking invalidation of each others trademark registrations for the drug.
In its verdict, the Delhi High court observed that is existed no case for passing of a temporary injunction at the present stage, as had been pressed for by
